HK1074451A1 - Therapeutic epitopes and uses thereof - Google Patents

Therapeutic epitopes and uses thereof

Info

Publication number
HK1074451A1
HK1074451A1 HK05108027.5A HK05108027A HK1074451A1 HK 1074451 A1 HK1074451 A1 HK 1074451A1 HK 05108027 A HK05108027 A HK 05108027A HK 1074451 A1 HK1074451 A1 HK 1074451A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic epitopes
epitopes
therapeutic
Prior art date
Application number
HK05108027.5A
Other languages
English (en)
Chinese (zh)
Inventor
R P Anderson
A V S Hill
Derek Parry Jewell
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Publication of HK1074451A1 publication Critical patent/HK1074451A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
HK05108027.5A 2002-06-05 2005-09-14 Therapeutic epitopes and uses thereof HK1074451A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0212885.8A GB0212885D0 (en) 2002-06-05 2002-06-05 Therapeutic epitopes and uses thereof
PCT/GB2003/002450 WO2003104273A2 (en) 2002-06-05 2003-06-05 Therapeutic epitopes and uses thereof

Publications (1)

Publication Number Publication Date
HK1074451A1 true HK1074451A1 (en) 2005-11-11

Family

ID=9937994

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05108027.5A HK1074451A1 (en) 2002-06-05 2005-09-14 Therapeutic epitopes and uses thereof
HK15106399.7A HK1205748A1 (en) 2002-06-05 2015-07-06 Therapeutic epitopes and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15106399.7A HK1205748A1 (en) 2002-06-05 2015-07-06 Therapeutic epitopes and uses thereof

Country Status (16)

Country Link
US (2) US10053497B2 (de)
EP (3) EP2292649B1 (de)
JP (6) JP2006512893A (de)
AU (1) AU2003244771B2 (de)
CA (1) CA2488218C (de)
CY (1) CY1115730T1 (de)
DK (1) DK1513873T3 (de)
ES (1) ES2510440T3 (de)
GB (1) GB0212885D0 (de)
HK (2) HK1074451A1 (de)
MX (2) MXPA04012117A (de)
NZ (1) NZ537226A (de)
PT (1) PT1513873E (de)
SI (1) SI1513873T1 (de)
WO (1) WO2003104273A2 (de)
ZA (1) ZA200409740B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923306D0 (en) 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
DK1572127T4 (da) 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
WO2003096979A2 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
DK1563300T3 (da) 2002-11-20 2012-07-23 Univ Leland Stanford Junior Diagnostisk fremgangsmåde til cøliaki
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
DE602005026287D1 (de) * 2004-04-16 2011-03-24 Univ Alberta Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
US7534426B2 (en) * 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US7563864B2 (en) * 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
EP2486934A1 (de) 2004-04-28 2012-08-15 BTG International Limited Epitope im Zusammenhang mit Zöliakie
AU2011247868B2 (en) * 2004-04-28 2014-05-22 Btg International Limited Epitopes related to coeliac disease
EP2136833B1 (de) 2007-03-16 2019-05-01 The Board of Trustees of the Leland Stanford Junior University Kombinationsenzymtherapie zum aufschluss von gluten in der nahrung
US8282928B2 (en) 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
DE102007044673A1 (de) * 2007-09-18 2009-03-19 Zimmer, Klaus-Peter, Prof. Dr. med. Impfstoff zur Behandlung von Zöliakie und Verfahren zur Herstellung des Impfstoffes, Verwendung einer mit einem bakteriellen Toxin konjugierten Peptidsequenz zur Aktivierung des Immunsystems gegen Prolamine sowie Designerpeptid
US8835603B2 (en) * 2008-11-30 2014-09-16 Immusant, Inc. Agents for the treatment of celiac disease
AU2013204429B9 (en) * 2008-11-30 2017-01-05 Immusant, Inc. Compositions and methods for treatment of celiac disease
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US20140037661A1 (en) * 2011-02-08 2014-02-06 Phadia Ab Wheat Antigens and Peptides for Diagnosis of Wheat Induced Hypersensitivity
ES2402286B1 (es) * 2011-09-29 2014-03-04 Universidad De Valladolid Péptido inmunogénico del gluten y sus aplicaciones.
CA3191015A1 (en) 2012-02-07 2013-08-15 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
WO2014127328A2 (en) 2013-02-15 2014-08-21 Vibrant Holdings, Llc. Methods and compositions for amplified electrochemiluminescence detection
EP3043812A1 (de) 2013-09-10 2016-07-20 Immusant Inc. Dosierung einer glutenpeptidzusammensetzung
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
EP3909603A1 (de) 2014-02-21 2021-11-17 Ecole Polytechnique Fédérale de Lausanne (EPFL) Glycotargeting-therapeutika
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3134737A4 (de) 2014-04-24 2018-01-17 Immusant Inc. Verfahren zur diagnose und behandlung von zöliakie bei kindern
NZ742911A (en) 2014-09-10 2024-02-23 Vibrant Holdings Llc Peptide microarrays and novel biomarkers for celiac disease
WO2016054038A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
AU2015349728A1 (en) 2014-11-21 2017-07-13 Immusant, Inc. Peptides for use in treatment and diagnosis of type 1 diabetes
EP3109255A1 (de) * 2015-06-26 2016-12-28 Institut National De La Recherche Agronomique Immunogene zusammensetzung
EP3313868A1 (de) * 2015-06-26 2018-05-02 Institut National De La Recherche Agronomique (INRA) Immunogene zusammensetzung
JP6738888B2 (ja) * 2016-02-23 2020-08-12 田中貴金属工業株式会社 グリアジン検出用免疫クロマト分析装置、免疫クロマト分析キットおよび免疫クロマト分析方法
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
JP6568193B2 (ja) * 2017-12-19 2019-08-28 ホーユー株式会社 エピトープ
US20220251148A1 (en) * 2019-07-04 2022-08-11 Ukko Inc. De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
EP4034144A1 (de) 2019-09-27 2022-08-03 Intrexon Actobiotics NV d/b/a Precigen Actobio Behandlung von zöliakie
GB202113858D0 (en) * 2021-09-28 2021-11-10 Nextera As Peptides

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459355A (en) 1982-07-12 1984-07-10 International Paper Company Method for transforming plant cells
US4536475A (en) 1982-10-05 1985-08-20 Phytogen Plant vector
NL8300698A (nl) 1983-02-24 1984-09-17 Univ Leiden Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
JPS6047683A (ja) 1983-08-24 1985-03-15 Kirin Brewery Co Ltd プロモ−タ−
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4943674A (en) 1987-05-26 1990-07-24 Calgene, Inc. Fruit specific transcriptional factors
DK162399C (da) 1986-01-28 1992-03-23 Danisco Fremgangsmaade til ekspression af gener i baelgplanteceller, dna-fragment, rekombineret dna-fragment samt plasmid til brug ved udoevelsen af fremgangsmaaden
ES2018274T5 (es) 1986-03-11 1996-12-16 Plant Genetic Systems Nv Celulas vegetales resistentes a los inhibidores de glutamina sintetasa, preparadas por ingenieria genetica.
US5107065A (en) 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5187073A (en) 1986-06-30 1993-02-16 The University Of Toledo Process for transforming gramineae and the products thereof
US5177010A (en) 1986-06-30 1993-01-05 University Of Toledo Process for transforming corn and the products thereof
NZ221259A (en) 1986-07-31 1990-05-28 Calgene Inc Seed specific transcriptional regulation
EP0267159A3 (de) 1986-11-07 1990-05-02 Ciba-Geigy Ag Verfahren zur genetischen Modifikation monokotyler Pflanzen
US4866247A (en) 1986-12-11 1989-09-12 The Lincoln Electric Company Apparatus and method of short circuiting arc welding
US4971908A (en) 1987-05-26 1990-11-20 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase
US5356799A (en) 1988-02-03 1994-10-18 Pioneer Hi-Bred International, Inc. Antisense gene systems of pollination control for hybrid seed production
US5371014A (en) 1988-02-12 1994-12-06 Daicel Chemical Industries, Ltd. Process for the production of optically active 2-hydroxy acid esters using microbes to reduce the 2-oxo precursor
US5179022A (en) 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
US5250515A (en) 1988-04-11 1993-10-05 Monsanto Company Method for improving the efficacy of insect toxins
US5565346A (en) 1988-07-27 1996-10-15 Calgene, Inc. Transformation and regeneration system for legumes
US5428146A (en) 1988-11-07 1995-06-27 Max-Planck-Gesellschaft Zur Forderung Wound-stimulated DNA-sequence from solanum tuberosum and its use
US5110732A (en) 1989-03-14 1992-05-05 The Rockefeller University Selective gene expression in plants
US5086169A (en) 1989-04-20 1992-02-04 The Research Foundation Of State University Of New York Isolated pollen-specific promoter of corn
US5629183A (en) 1989-05-08 1997-05-13 The United States Of America As Represented By The Secretary Of Agriculture Plant transformation by gene transfer into pollen
US5097025A (en) 1989-08-01 1992-03-17 The Rockefeller University Plant promoters
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
JPH05501352A (ja) 1989-08-09 1993-03-18 ディカルブ　ジェネティクス　コーポレイション 安定な形質転換稔性単子葉植物およびそれらの細胞を製造するための方法および組成物
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US4919813A (en) 1989-08-25 1990-04-24 The United States Of America As Represented By The Department Of Energy Photoenhanced anaerobic digestion of organic acids
EP0497884B1 (de) 1989-10-27 2004-04-28 The Salk Institute For Biological Studies Rezeptorverbindungen von glutamin und herstellung
US5589583A (en) 1990-01-11 1996-12-31 Monsanto Company Plant promoter
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
HU220773B1 (hu) 1990-01-22 2002-05-28 Dekalb Genetics Corporation Eljárás termő transzgenikus kukoricanövények előállítására
EP0442174A1 (de) 1990-02-13 1991-08-21 Pioneer Hi-Bred International, Inc. Stabile Transformation von Pflanzenzellen
US5618988A (en) 1990-03-02 1997-04-08 Amoco Corporation Enhanced carotenoid accumulation in storage organs of genetically engineered plants
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5187267A (en) 1990-06-19 1993-02-16 Calgene, Inc. Plant proteins, promoters, coding sequences and use
AU655197B2 (en) 1990-06-25 1994-12-08 Monsanto Technology Llc Glyphosate tolerant plants
NZ239977A (en) 1990-11-14 1993-08-26 Pioneer Hi Bred Int Transforming plants by the use of agrobacterium
US5932782A (en) 1990-11-14 1999-08-03 Pioneer Hi-Bred International, Inc. Plant transformation method using agrobacterium species adhered to microprojectiles
EP0559742A1 (de) 1990-11-26 1993-09-15 E.I. Du Pont De Nemours And Company Herbizide oxazinether
US5459252A (en) 1991-01-31 1995-10-17 North Carolina State University Root specific gene promoter
EP0570422B1 (de) 1991-02-07 2007-12-19 Bayer BioScience N.V. Staubblatt spezifische promotoren aus mais
IL101508A0 (en) 1991-04-08 1992-12-30 Rhone Poulenc Agrochimie Chimeric plant genes based on upstream regulatory elements of helianthinin
DE69232132T3 (de) 1991-05-15 2008-08-14 Monsanto Technology Llc. Verfahren zur schöpfung einer transformierten reispflanze
WO1993004178A1 (en) 1991-08-23 1993-03-04 University Of Florida A novel method for the production of transgenic plants
WO1994000977A1 (en) 1992-07-07 1994-01-20 Japan Tobacco Inc. Method of transforming monocotyledon
NZ257181A (en) 1992-10-29 1997-07-27 Medical Res Council Transcription factor dp-1, dna, vectors and host cells therefor
US5389226A (en) 1992-12-17 1995-02-14 Amorphous Technologies International, Inc. Electrodeposition of nickel-tungsten amorphous and microcrystalline coatings
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
WO1994025613A1 (en) 1993-05-03 1994-11-10 Cornell Research Foundation, Inc. Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
US5670349A (en) 1993-08-02 1997-09-23 Virginia Tech Intellectual Properties, Inc. HMG2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
EP0672752B1 (de) 1993-09-03 2004-05-26 Japan Tobacco Inc. Verfahren zur transformation von monocotyledonen mittels des schildes von unreifen embryonen
US5495007A (en) 1994-04-29 1996-02-27 Thompson; Gary A. Phloem-specific promoter
US5633363A (en) 1994-06-03 1997-05-27 Iowa State University, Research Foundation In Root preferential promoter
US5646333A (en) 1994-09-02 1997-07-08 Drexel University Plant promoter useful for directing the expression of foreign proteins to the plant epidermis
HUT76355A (en) 1995-11-24 1997-08-28 Bay Zoltan Alkalmazott Kutatas Plant gene-expression vector family based on dna fragments regulating alfalfa h3 histon gene variant (ms h3g1)
US6036983A (en) 1996-05-20 2000-03-14 Novo Nordisk A/S Method of obtaining protein hydrolysates
CA2257972A1 (en) 1996-06-13 1997-12-18 Consejo Superior De Investigaciones Cientificas Plant proteins
GB9624456D0 (en) 1996-11-25 1997-01-15 Isis Innovation Assay method
US5959175A (en) 1997-04-09 1999-09-28 Thomas; Terry L. Sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
US5977436A (en) 1997-04-09 1999-11-02 Rhone Poulenc Agrochimie Oleosin 5' regulatory region for the modification of plant seed lipid composition
ES2132025B1 (es) 1997-06-12 2000-12-01 Consejo Superior Investigacion Proteinas urag de las plantas.
EP0905518A1 (de) 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
US6100450A (en) 1997-10-22 2000-08-08 Rhone-Poulenc Agrochimie Seed specific promoters based on arabidopsis genes
US6232445B1 (en) 1997-10-29 2001-05-15 Sunol Molecular Corporation Soluble MHC complexes and methods of use thereof
EP1068334A2 (de) 1998-04-09 2001-01-17 E.I. Du Pont De Nemours And Company Zellzyklus-regulierende proteine cdc-16, dp-1, dp-2 und e2f aus pflanzen
WO1999058681A2 (en) 1998-05-08 1999-11-18 Consejo Superior De Investigaciones Cientificas Transgenic plant cells expressing a recombinant plant e2f peptide
CA2341760A1 (en) * 1998-09-03 2000-03-16 Pia Vaag 17 kda foam protein
AU3230200A (en) 1999-02-12 2000-08-29 Pioneer Hi-Bred International, Inc. Transgenic plants with modified expression of the dp protein
GB9923306D0 (en) * 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
MXPA03009313A (es) * 2001-04-12 2004-11-12 Academish Ziekenhuis Leiden Metodos y medios para uso de receptores de celulas t restringidos por hla-dq y peptidos derivados de prolamina unidos a hla-dq.
EP1332760A1 (de) 2002-02-04 2003-08-06 Academisch Ziekenhuis Leiden Neue Epitope für Zöliakie und Autoimmunerkrankungen, Methoden zu deren Detektion und neue nichtantigene Futterzusätze
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
DK1572127T4 (da) * 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
US7202216B2 (en) 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
WO2003096979A2 (en) 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
DK1563300T3 (da) 2002-11-20 2012-07-23 Univ Leland Stanford Junior Diagnostisk fremgangsmåde til cøliaki
US6992916B2 (en) 2003-06-13 2006-01-31 Taiwan Semiconductor Manufacturing Co., Ltd. SRAM cell design with high resistor CMOS gate structure for soft error rate improvement
EP2486934A1 (de) 2004-04-28 2012-08-15 BTG International Limited Epitope im Zusammenhang mit Zöliakie
US8835603B2 (en) * 2008-11-30 2014-09-16 Immusant, Inc. Agents for the treatment of celiac disease
JP6520175B2 (ja) 2015-02-10 2019-05-29 富士通株式会社 無線通信装置、基地局システム及び無線通信装置制御方法

Also Published As

Publication number Publication date
JP2015052599A (ja) 2015-03-19
WO2003104273A9 (en) 2005-01-13
JP2016122016A (ja) 2016-07-07
EP1513873B1 (de) 2014-08-13
EP1513873A2 (de) 2005-03-16
JP2010229138A (ja) 2010-10-14
CA2488218A1 (en) 2003-12-18
HK1205748A1 (en) 2015-12-24
CY1115730T1 (el) 2017-01-25
JP2015028025A (ja) 2015-02-12
JP6055689B2 (ja) 2016-12-27
WO2003104273A3 (en) 2004-09-23
EP2292649A2 (de) 2011-03-09
EP2292649B1 (de) 2014-10-29
AU2003244771B2 (en) 2010-01-07
JP6438423B2 (ja) 2018-12-12
JP5635302B2 (ja) 2014-12-03
ZA200409740B (en) 2006-09-27
PT1513873E (pt) 2014-11-04
SI1513873T1 (sl) 2014-12-31
EP2826787B1 (de) 2020-10-28
JP5977293B2 (ja) 2016-08-24
AU2003244771A1 (en) 2003-12-22
MX338122B (es) 2016-04-04
JP2013101146A (ja) 2013-05-23
MXPA04012117A (es) 2005-04-19
US10053497B2 (en) 2018-08-21
CA2488218C (en) 2020-11-10
NZ537226A (en) 2008-06-30
EP2292649A3 (de) 2011-07-06
JP2006512893A (ja) 2006-04-20
ES2510440T3 (es) 2014-10-21
US20060178299A1 (en) 2006-08-10
WO2003104273A2 (en) 2003-12-18
US20180334484A1 (en) 2018-11-22
DK1513873T3 (da) 2014-11-03
EP2826787A1 (de) 2015-01-21
GB0212885D0 (en) 2002-07-17

Similar Documents

Publication Publication Date Title
HK1205748A1 (en) Therapeutic epitopes and uses thereof
HK1204654A1 (en) Therapeutic human anti-il-1r1 monoclonal antibody -il-1r1
EP1572131A4 (de) Antikörper-therapie
GB0206876D0 (en) Therapeutic agents
GB0209991D0 (en) Therapeutic agents
GB0209995D0 (en) Therapeutic agents
GB0209997D0 (en) Therapeutic agents
GB0210127D0 (en) Therapeutic agents
GB0210124D0 (en) Therapeutic agents
GB0223349D0 (en) Therapeutic agents
EP1682136A4 (de) Therapeutische verbindungen und ihre verwendungen
GB0212405D0 (en) Composition and its therapeutic use
AU2003255544A8 (en) Tumor specific oligosaccharide epitopes and use thereof
GB0219660D0 (en) Therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
GB0218876D0 (en) Therapeutic agents
EP1701736A4 (de) Therapeutische mittel und ihre verwendungen
GB0217068D0 (en) Therapeutic agents
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
EP1569928A4 (de) Therapeutische verbindungen und verfahren
GB0208394D0 (en) Therapeutic agents
AU2003231937A8 (en) Therapeutic methods
GB0205826D0 (en) Therapeutic compositions and methods
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2003953561A0 (en) Peptides and therapeutic uses thereof

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230604